Taurine

Taurine

SCHEMBL7213501

NCCO.NCCS(=O)(=O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Taurine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.82
BLM P54132 3/20 0.82
SLC6A6 P31641 1/20 0.82
CYP2C19 P33261 1/20 0.82
APP P05067 1/20 0.57
ALDH1A1 P00352 5/20 0.47
TSHR P16473 3/20 0.47
PTGS1 P23219 1/20 0.41
PDE4A P27815 1/20 0.41
HPGD P15428 1/20 0.35
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
NT5E P21589 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Taurine SCHEMBL1826395 1.00 LMNA (0.82) LMNABLMSLC6A6CYP2C19APP
Taurine SCHEMBL27709203 0.97 LMNA (0.78) LMNABLMSLC6A6CYP2C19APP
Taurine SCHEMBL8698527 0.94 LMNA (0.82) LMNABLMSLC6A6CYP2C19APP
Taurine SCHEMBL9902206 0.92 LMNA (0.70) LMNABLMSLC6A6CYP2C19APP
Taurine SCHEMBL42632 0.91 BLM (1.00) LMNABLMSLC6A6CYP2C19APP
Taurine SCHEMBL30191395 0.91
Taurine SCHEMBL23068 0.91
Taurine SCHEMBL30179154 0.91
Monoethanolamine SCHEMBL9784964 0.88 LMNA (0.63) LMNABLMSLC6A6CYP2C19APP
Taurine SCHEMBL3667691 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101678152-B Methods for pre-stressing and capping bioprosthetic tissue EDWARDS LIFESCIENCES CORP 2013-06-26 CN disclosed
CN-101678152-A methods for pre-stressing and capping bioprosthetic tissue EDWARDS LIFESCIENCES CORP 2010-03-24 CN disclosed
US-6617390-B2 Catalytic polymerization of acrylic acid-acrylonitrile block copolymer; improved hydrophobic/hydrophilic distribution; thermal stability REPLICATION MEDICAL, INC. 2003-09-09 US disclosed
US-20020193531-A1 Method of making synthetic hydrophilic polymers and products resulting therefrom REPLICATION MEDICAL, INC. 2002-12-19 US disclosed
US-6451922-B2 TWO STAGE CATALYTIC REACTION OF POLYACRYLONITRILE IN PRESENCE AND ABSENCE OF SOLVENT TO FORM MULTIBLOCK POLYMER OF ACRYLIC ACID SALT, ACRYLAMIDE AND ACRYLIC ACID DERIVATIVE; MECHANICAL AND THERMAL STABILITY; COSMETICS; THICKENER; EMULSIFIER REPLICATION MEDICAL, INC. 2002-09-17 US disclosed
US-20010044502-A1 Method of making synthetic hydrophilic polymers and products resulting therefrom REPLICATION MEDICAL, INC. 2001-11-22 US disclosed